ERBB2 and breast cancer: In addition, further dissecting the mutation data into different cancer subtype groups (such as MSI and non-MSI in colorectal cancer, ER+, HER2+ and TNBC in breast cancer) would be helpful to distinguish distinct mutation profiles and precisely investigate the specific function of hotspot mutations in different cancer subtypes.